EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

Peripheral blood-derived CD34+ or mononuclear cells for liver cirrhosis

The aim of this trial is to assess the safety and efficacy of infusion of either peripheral blood-derived mononuclear cells (PB-MNCs) or peripheral blood-derived CD34+ cells (PB-CD3+) in patients with liver cirrhosis.
See additional Cell Therapies for: Liver
Peripheral blood-derived CD34+ or mononuclear cells for liver cirrhosis
Home
Contact Us
About Terms of Use Privacy Policy
Copyright LifeMap Sciences, Inc. - All Rights Reserved (v4.14 Build 1)
This site does not provide medical advice and is for research use only